drugset
Drugs / CENSAVUDINE
last change Aug 2026 re-read 9 days ago

CENSAVUDINE

also known as 4'-ed4t · 4'-ethynyl stavudine · BMS-986001 · Censavudina · Censavudine, 4'-ethynyl-d4t · Festinavir · OBP-601

Small molecule

Developed for
HIV infectious disease
Investigated by
Bristol-Myers Squibb

Trials 1

today NCT01489046 · Ph 2
20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01489046 Feb 2011 → Mar 2013 HIV infectious disease Bristol-Myers Squibb Terminated No outcome recorded

Press releases naming this drug 34 releases

DateIssuerRelease
2026-08-27 Oncolys BioPharma Inc LINE-1 阻害剤センサブジン（OBP-601）の oncolys.com ↗
2026-03-23 Oncolys BioPharma Inc OBP-601 の神経変性疾患への特許に関するお知らせ oncolys.com ↗
2025-07-10 Oncolys BioPharma Inc LINE-1 阻害剤 OBP-601 に対する ADDF oncolys.com ↗
2025-05-30 Oncolys BioPharma Inc LINE-1阻害剤OBP-601（censavudine）の oncolys.com ↗
2024-12-04 Oncolys BioPharma Inc International Symposium on ALS/MNDにおける OBP-601 の oncolys.com ↗
2024-11-07 Oncolys BioPharma Inc Annual ALS Research Symposium における OBP-601 の oncolys.com ↗
2024-10-11 Oncolys BioPharma Inc 2024 Annual NEALS Meeting における OBP-601 の oncolys.com ↗
2024-07-25 Oncolys BioPharma Inc OBP-601（censavudine, TPN-101）の C-9 ALS Phase2a 試験の oncolys.com ↗
2024-05-22 Oncolys BioPharma Inc 進行性核上性麻痺（PSP）における OBP-601（censavudine, TPN-101）の oncolys.com ↗
2024-02-14 Oncolys BioPharma Inc OBP-601（censavudine, TPN-101）の PSP Phase2a 試験に関する最終解析結果、 oncolys.com ↗
2023-07-25 Oncolys BioPharma Inc Announcement of Enrollment of First Patient in Phase IIa study for OBP-601 in patients with AGS oncolys.com ↗
2023-07-25 Oncolys BioPharma Inc OBP-601（censavudine, TPN-101）の oncolys.com ↗

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as CENSAVUDINE ChEMBL registry synonym — accepted as the source's own label CHEMBL124363 ↗
Known as 4'-ed4t ChEMBL registry synonym — accepted as the source's own label CHEMBL124363 ↗
Known as 4'-ethynyl stavudine ChEMBL registry synonym — accepted as the source's own label CHEMBL124363 ↗
Known as BMS-986001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01489046 ↗
Known as Censavudina ChEMBL registry synonym — accepted as the source's own label CHEMBL124363 ↗
Known as Censavudine, 4'-ethynyl-d4t ChEMBL registry synonym — accepted as the source's own label CHEMBL124363 ↗
Known as Festinavir ChEMBL registry synonym — accepted as the source's own label CHEMBL124363 ↗
Known as OBP-601 ChEMBL registry synonym — accepted as the source's own label CHEMBL124363 ↗
Action Inhibit “BMS-986001 is a thymidine analogue nucleoside reverse transcriptase inhibitor (NRTI)” PMID 26762988 ↗ Dec 2015
Modality Small molecule “BMS-986001 is a thymidine analogue nucleoside reverse transcriptase inhibitor (NRTI)” PMID 26762988 ↗ Dec 2015
Route Oral “Capsules, Oral” NCT01489046 ↗